<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cfpd</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень физиологии и патологии дыхания</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin Physiology and Pathology of Respiration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1998-5029</issn><publisher><publisher-name>Дальневосточный научный центр физиологии и патологии дыхания</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.36604/1998-5029-2024-94-80-86</article-id><article-id custom-type="elpub" pub-id-type="custom">cfpd-1208</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Особенности экспрессии каналов TRPV1 и TRPV4 на  субпопуляциях моноцитов периферической крови больных ХОБЛ</article-title><trans-title-group xml:lang="en"><trans-title>Features of TRPV1 and TRPV4 channels expression on subpopulations of peripheral blood monocytes in patients with COPD</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гассан</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gassan</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дина Анатольевна Гассан, канд. мед. наук, зав. лабораторией вирус-ассоциированных патологий развития</p><p>675000, г. Благовещенск, ул. Калинина, 22</p></bio><bio xml:lang="en"><p>Dina A. Gassan, PhD (Med.), Head of Laboratory of Mechanisms of Virus-Associated Developmental Pathologies</p><p>22 Kalinina Str., Blagoveshchensk, 675000</p></bio><email xlink:type="simple">dani-shi@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Наумов</surname><given-names>Д. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Naumov</surname><given-names>D. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Денис Евгеньевич Наумов, канд. мед. наук, зав. лабораторией молекулярных и трансляционных исследований</p><p>675000, г. Благовещенск, ул. Калинина, 22</p></bio><bio xml:lang="en"><p>Denis E. Naumov, PhD (Med.), Head of Laboratory of Molecular and Translational Research</p><p>22 Kalinina Str., Blagoveshchensk, 675000</p></bio><email xlink:type="simple">denn1985@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сугайло</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Sugaylo</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ивана Юрьевна Сугайло, канд. мед. наук, научный сотрудник, лаборатория молекулярных и трансляционных исследований</p><p>675000, г. Благовещенск, ул. Калинина, 22</p></bio><bio xml:lang="en"><p>Ivana Yu. Sugaylo, PhD (Med.), Staff Scientist, Laboratory of Molecular and Translational Research</p><p>22 Kalinina Str., Blagoveshchensk, 675000</p></bio><email xlink:type="simple">ivanka_888@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Котова</surname><given-names>О. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotova</surname><given-names>O. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Олеся Олеговна Котова, канд. мед. наук, старший научный сотрудник, лаборатория вирус-ассоциированных патологий развития</p><p>675000, г. Благовещенск, ул. Калинина, 22</p></bio><bio xml:lang="en"><p>Olesya O. Kotova, PhD (Med.), Senior Staff Scientist, Laboratory of Mechanisms of Virus-Associated Developmental Pathologies</p><p>22 Kalinina Str., Blagoveshchensk, 675000</p></bio><email xlink:type="simple">foxy_voxy_on@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мальцева</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Maltseva</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мальцева Татьяна Анатольевна, канд. мед. наук, научный сотрудник, лаборатория молекулярных и трансляционных исследований</p><p>675000, г. Благовещенск, ул. Калинина, 22</p></bio><bio xml:lang="en"><p>Tatiana А. Maltseva, PhD (Med.), Staff Scientist, Laboratory of Molecular and Translational Research</p><p>22 Kalinina Str., Blagoveshchensk, 675000</p></bio><email xlink:type="simple">malta-82@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колосов</surname><given-names>В. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolosov</surname><given-names>V. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Виктор Павлович Колосов, академик РАН, д-р мед. наук, профессор, научный руководитель</p><p>675000, г. Благовещенск, ул. Калинина, 22</p></bio><bio xml:lang="en"><p>Victor P. Kolosov, MD, PhD, DSc (Med.), Academician of RAS, Professor, Scientific Director</p><p>22 Kalinina Str., Blagoveshchensk, 675000</p></bio><email xlink:type="simple">kolosov@amur.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральное государственное бюджетное научное учреждение «Дальневосточный научный центр физиологии и патологии дыхания»<country>Россия</country></aff><aff xml:lang="en">Far Eastern Scientific Center of Physiology and Pathology of Respiration<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>12</month><year>2024</year></pub-date><volume>0</volume><issue>94</issue><fpage>80</fpage><lpage>86</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гассан Д.А., Наумов Д.Е., Сугайло И.Ю., Котова О.О., Мальцева Т.А., Колосов В.П., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Гассан Д.А., Наумов Д.Е., Сугайло И.Ю., Котова О.О., Мальцева Т.А., Колосов В.П.</copyright-holder><copyright-holder xml:lang="en">Gassan D.A., Naumov D.E., Sugaylo I.Y., Kotova O.O., Maltseva T.A., Kolosov V.P.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cfpd.elpub.ru/jour/article/view/1208">https://cfpd.elpub.ru/jour/article/view/1208</self-uri><abstract><p>Введение. Хроническая обструктивная болезнь легких (ХОБЛ) является распространенным гетерогенным заболеванием, основными этиологическими факторами которого является табакокурение и действие аэрополлютантов. Моноциты, как и макрофаги, являются наиболее важными клетками, участвующими в патогенезе ХОБЛ. Установлено, что TRP-каналы могут активироваться в ответ на действие сигаретного дыма в моделях респираторных заболеваний. Ранее нам удалось определить влияние TRP-каналов на прогрессирование бронхиальной обструкции и особенности их экспрессии на лейкоцитах периферической крови у больных ХОБЛ. Цель. Изучить особенности экспрессии каналов TRPV1 и TRPV4 на субпопуляциях моноцитов периферической крови больных ХОБЛ. Материалы и методы. В исследование было включено 47 больных ХОБЛ с разной степенью тяжести и 25 лиц контрольной группы. Субпопуляции моноцитов, а также экспрессию рецепторов TRPV1, TRPV4 определяли методом проточной цитометрии. Результаты. Канал TRPV1 больше экспрессировался на моноцитах больных ХОБЛ (99,1 (98,6-99,6)% против 97,7 (95,6-99,5)% в контрольной группе, p=0,07). При анализе субпопу- ляций моноцитов было установлено, что экспрессия TRPV1 была увеличена на неклассических моноцитах больных ХОБЛ (94,5 (91,5-97,2) против 88,0 (71,5-95,1) в контрольной группе, p=0,04). Увеличение экспрессии TRPV1 и TRPV4 на неклассических моноцитах было ассоциировано с уменьшением на них числа CD115 рецепторов. Корреляции TRPV1 c экспрессией CD115, выраженной в %, составили ρ=-0,31, p=0,07. Корреляции для канала TRPV4 c экспрессией CD115 составили ρ=-0,31, p=0,08. Повышенное соотношение CD116/CD115 на неклассических моноцитах также сопровождалось ростом экспрессии каналов TRPV1 на данных клетках (ρ=0,35, p=0,04). Заключение. В ходе проведенного исследования было установлено, что больные ХОБЛ, по сравнению с контрольной группой, характеризуются более высокой экспрессией TRPV1 на неклассических моноцитах. Также было определено, что повышенная экспрессия TRPV1 и TRPV4 ассоциирована с формированием провоспалительного фенотипа моноцитов.</p></abstract><trans-abstract xml:lang="en"><p>Introduction. Chronic Obstructive Pulmonary Disease (COPD) is a widespread heterogeneous disease, with smoking and exposure to air pollutants being the main etiological factors. Monocytes and macrophages are among the most important cells involved in the pathogenesis of COPD. It has been established that TRP channels can be activated in response to cigarette smoke in models of respiratory diseases. Previously, we identified the influence of TRP channels on the progression of bronchial obstruction and the peculiarities of their expression on peripheral blood leukocytes in patients with COPD. Aim. To study the features of TRPV1 and TRPV4 channels expression on subpopulations of peripheral blood monocytes in patients with COPD. Materials and methods. The study included 47 patients with COPD of varying severity and 25 individuals in the control group. Monocytes subpopulations and the expression of TRPV1 and TRPV4 receptors were determined by flow cytometry. Results. The TRPV1 channels had higher expression on monocytes of COPD patients (99.1 [98.6–99.6]% vs. 97.7 [95.6–99.5]%, p = 0.07). Analysis of monocyte subpopulations revealed that TRPV1 expression was increased on non-classical monocytes of COPD patients (94.5 [91.5–97.2] vs. 88.0 [71.5–95.1], p = 0.04). An increase in TRPV1 and TRPV4 expression on non-classical monocytes was associated with a decrease in the number of CD115 receptors on these cells. Correlations between TRPV1 and CD115 expression, expressed as a percentage, were ρ = -0.31, p = 0.07. Correlations for the TRPV4 channel with CD115 expression were ρ = -0.31, p = 0.08. An increased CD116/CD115 ratio on non-classical monocytes was also accompanied by a rise in TRPV1 channels expression on these cells (ρ = 0.35, p = 0.04). Conclusion. The study established that COPD patients, as compared to the control group, exhibit higher TRPV1 expression on non-classical monocytes. It was also determined that increased expression of TRPV1 and TRPV4 is associated with the formation of a pro-inflammatory phenotype of monocytes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>TRP-каналы</kwd><kwd>моноциты</kwd><kwd>ХОБЛ</kwd><kwd>курение</kwd></kwd-group><kwd-group xml:lang="en"><kwd>TRP-channels</kwd><kwd>monocytes</kwd><kwd>COPD</kwd><kwd>smoking</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Исследование выполнено в рамках программы фундаментальных исследований Министерства науки и  высшего образования РФ (FGWF-2022-0005)</funding-statement></funding-group><funding-group xml:lang="en"><funding-statement>This study was supported by the Ministry of Science  and Higher Education of the Russian Federation under the  Program for Basic Research (FGWF-2022-0005)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Update 2024). URL: http://www.goldcopd.org</mixed-citation><mixed-citation xml:lang="en">Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Update 2024). URL: http://www.goldcopd.org</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Iheanacho I., Zhang S., King D., Rizzo M., Ismaila A.S. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review // Int. J. Chron. Obstruc. Pulmon. Dis. 2020. Vol.15. P.439–460. https://doi.org/10.2147/COPD.S234942</mixed-citation><mixed-citation xml:lang="en">Iheanacho I., Zhang S., King D., Rizzo M., Ismaila A.S. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review // Int. J. Chron. Obstruc. Pulmon. Dis. 2020. Vol.15. P.439–460. https://doi.org/10.2147/COPD.S234942</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wachami A.L., Guennouni N., Iderdar Y. Boumendil K., Arraji M., Mourajid Y., Bouchachi F.Z., Barkaoui M., Louerdi M.L., Hilali A., Chahboune M. Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis // BMC Public Health. 2024. Vol.24, Iss.1. Article number:297. https://doi.org/10.1186/s12889-024-17686-9</mixed-citation><mixed-citation xml:lang="en">Wachami A.L., Guennouni N., Iderdar Y. Boumendil K., Arraji M., Mourajid Y., Bouchachi F.Z., Barkaoui M., Louerdi M.L., Hilali A., Chahboune M. Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis // BMC Public Health. 2024. Vol.24, Iss.1. Article number:297. https://doi.org/10.1186/s12889-024-17686-9</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Patel N. An update on COPD prevention, diagnosis, and management: the 2024 GOLD report // Nurse Pract. 2024. Vol.49, Iss 6. P.29–36. https://doi.org/10.1097/01.NPR.0000000000000180</mixed-citation><mixed-citation xml:lang="en">Patel N. An update on COPD prevention, diagnosis, and management: the 2024 GOLD report // Nurse Pract. 2024. Vol.49, Iss 6. P.29–36. https://doi.org/10.1097/01.NPR.0000000000000180</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Guilliams M., Mildner A., Yona S. Developmental and functional heterogeneity of monocytes // Immunity. 2018. Vol.49, Iss.4. P.595–613. https://doi.org/10.1016/j.immuni.2018.10.005</mixed-citation><mixed-citation xml:lang="en">Guilliams M., Mildner A., Yona S. Developmental and functional heterogeneity of monocytes // Immunity. 2018. Vol.49, Iss.4. P.595–613. https://doi.org/10.1016/j.immuni.2018.10.005</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ziegler-Heitbrock L. Blood monocytes and their subsets: established features and open questions // Front. Immunol. 2015. Vol.6. Article number:423. https://doi:10.3389/fimmu.2015.00423</mixed-citation><mixed-citation xml:lang="en">Ziegler-Heitbrock L. Blood monocytes and their subsets: established features and open questions // Front. Immunol. 2015. Vol.6. Article number:423. https://doi:10.3389/fimmu.2015.00423</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Barnes P.J. Similarities and differences in inflammatory mechanisms of asthma and COPD // Breathe. 2011. Vol.7, Iss.3. P.229–238. https://doi.org/10.1183/20734735.026410</mixed-citation><mixed-citation xml:lang="en">Barnes P.J. Similarities and differences in inflammatory mechanisms of asthma and COPD // Breathe. 2011. Vol.7, Iss.3. P.229–238. https://doi.org/10.1183/20734735.026410</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sangani R.G., Deepak V., Anwar J., Patel Z., Ghio A.J. Cigarette smoking, and blood monocyte count correlate with chronic lung injuries and mortality // Int. J. Chron. Obstruct. Pulmon. Dis. 2023. Vol.18. P.431–446. https://doi.org/10.2147/COPD.S397667</mixed-citation><mixed-citation xml:lang="en">Sangani R.G., Deepak V., Anwar J., Patel Z., Ghio A.J. Cigarette smoking, and blood monocyte count correlate with chronic lung injuries and mortality // Int. J. Chron. Obstruct. Pulmon. Dis. 2023. Vol.18. P.431–446. https://doi.org/10.2147/COPD.S397667</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cornwell W.D., Kim V., Fan X., Vega M.E., Ramsey F.V., Criner G.J., Rogers T.J. Activation and polarization of circulating monocytes in severe chronic obstructive pulmonary disease // BMC Pulm. Med. 2018. Vol.18, Iss.1. Article number:101. https://doi.org/10.1186/s12890-018-0664-y</mixed-citation><mixed-citation xml:lang="en">Cornwell W.D., Kim V., Fan X., Vega M.E., Ramsey F.V., Criner G.J., Rogers T.J. Activation and polarization of circulating monocytes in severe chronic obstructive pulmonary disease // BMC Pulm. Med. 2018. Vol.18, Iss.1. Article number:101. https://doi.org/10.1186/s12890-018-0664-y</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Q., Wang Y., Zhang L., Qian W., Shen S., Wang J., Wu S., Xu W., Chen B., Lin M., Wu J. Single-cell transcriptomics highlights immunological dysregulations of monocytes in the pathobiology of COPD // Respir. Res. 2022. Vol.23, Iss.1. Article number:367. https://doi.org/10.1186/s12931-022-02293-2</mixed-citation><mixed-citation xml:lang="en">Huang Q., Wang Y., Zhang L., Qian W., Shen S., Wang J., Wu S., Xu W., Chen B., Lin M., Wu J. Single-cell transcriptomics highlights immunological dysregulations of monocytes in the pathobiology of COPD // Respir. Res. 2022. Vol.23, Iss.1. Article number:367. https://doi.org/10.1186/s12931-022-02293-2</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wu J., Li Z., Deng Y., Lu X., Luo C., Mu X., Zhang T., Liu Q., Tang S., Li J., An Q., Fan D., Xiang Y., Wu X., Hu Y., Du Q., Xu J., Xie R. Function of TRP channels in monocytes/macrophages // Front. Immunol. 2023. Vol.14. Article number:1187890. https://doi.org/10.3389/fimmu.2023.1187890</mixed-citation><mixed-citation xml:lang="en">Wu J., Li Z., Deng Y., Lu X., Luo C., Mu X., Zhang T., Liu Q., Tang S., Li J., An Q., Fan D., Xiang Y., Wu X., Hu Y., Du Q., Xu J., Xie R. Function of TRP channels in monocytes/macrophages // Front. Immunol. 2023. Vol.14. Article number:1187890. https://doi.org/10.3389/fimmu.2023.1187890</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Grace M.S., Baxter M., Dubuis E., Birrell M.A., Belvisi M.G. Transient receptor potential (TRP) channels in the airway: role in airway disease // Br. J. Pharmacol. 2014. Vol.171, Iss.10. P.2593–2607. https://doi.org/10.1111/bph.12538</mixed-citation><mixed-citation xml:lang="en">Grace M.S., Baxter M., Dubuis E., Birrell M.A., Belvisi M.G. Transient receptor potential (TRP) channels in the airway: role in airway disease // Br. J. Pharmacol. 2014. Vol.171, Iss.10. P.2593–2607. https://doi.org/10.1111/bph.12538</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Наумов Д.Е., Сугайло И.Ю., Гассан Д.А., Котова О.О., Горчакова Я.Г., Шелудько Е.Г. Особенности экспрессии TRP каналов и цитокиновый профиль мокроты у больных хронической обструктивной болезнью легких с прогрессирующей бронхиальной обструкцией // Бюллетень физиологии и патологии дыхания. 2022. Вып.86. С.24–32. https://doi.org/10.36604/1998-5029-2022-86-24-32</mixed-citation><mixed-citation xml:lang="en">Naumov D.E., Sugaylo I.Yu., Kotova O.O., Gassan D.A., Gorchakova Y.G., Sheludko E.G. [Peculiarities of TRP channels expression and cytokine profile of sputum in patients with chronic obstructive pulmonary disease and progressive bronchial obstruction]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2023; 38(4):125–132 (in Russian). https://doi.org/10.29001/2073-8552-2023-659</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kunde D.A., Yingchoncharoen J., Jurković S., Geraghty D.P. TRPV1 mediates capsaicin-stimulated metabolic activity but not cell death or inhibition of interleukin-1β release in human THP-1 monocytes // Toxicol. Appl. Pharmacol. 2018. Vol.360. P.9–17. https://doi.org/10.1016/j.taap.2018.09.025</mixed-citation><mixed-citation xml:lang="en">Kunde D.A., Yingchoncharoen J., Jurković S., Geraghty D.P. TRPV1 mediates capsaicin-stimulated metabolic activity but not cell death or inhibition of interleukin-1β release in human THP-1 monocytes // Toxicol. Appl. Pharmacol. 2018. Vol.360. P.9–17. https://doi.org/10.1016/j.taap.2018.09.025</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Boonen B., Alpizar Y.A., Sanchez A., López-Requena A., Voets T., Talavera K. Differential effects of lipopolysaccharide on mouse sensory TRP channels // Cell Calcium. 2018. Vol.73. P.72–81. https://doi.org/10.1016/j.ceca.2018.04.004</mixed-citation><mixed-citation xml:lang="en">Boonen B., Alpizar Y.A., Sanchez A., López-Requena A., Voets T., Talavera K. Differential effects of lipopolysaccharide on mouse sensory TRP channels // Cell Calcium. 2018. Vol.73. P.72–81. https://doi.org/10.1016/j.ceca.2018.04.004</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Гассан Д.А., Наумов Д.Е., Сугайло И.Ю., Котова О.О., Горчакова Я.Г., Афанасьева Е.Ю. Особенности экспрессии рецепторов к гранулоцитарно-макрофагальному и макрофагальному колониестимулирующим факторам на субпопуляциях моноцитов периферической крови больных хронической обструктивной болезнью легких // Бюллетень физиологии и патологии дыхания. 2024. Вып.93. С.38–47. https://doi.org/10.36604/1998-5029-2024-93-38-47</mixed-citation><mixed-citation xml:lang="en">Gassan D.A., Naumov D.E., Sugaylo I.Yu., Kotova O.O., Gorchakova Y.G., Afanas’eva E.Yu. [Peculiarities of granulocyte-macrophage and macrophage colony-stimulating factors receptors expression in subpopulations of peripheral blood monocytes of patients with chronic obstructive pulmonary disease]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2024; 93:38–47 (in Russian). https://doi.org/10.36604/1998-5029-2024-93-38-47</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
